Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

463.86 -5.82 (-1.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
69 70 Next >
News headline image
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel 
Via MarketBeat
News headline image
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires ↗
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations. 
Via InvestorPlace
News headline image
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now ↗
It's always a good time to buy great stocks with excellent prospects. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation ↗
There's no need for delays in buying these great stocks. 
Via The Motley Fool
News headline image
Forget Tesla, Buy This Magnificent Healthcare Stock Instead ↗
Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future. 
Via The Motley Fool
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,500 Today ↗
 
Via Benzinga
News headline image
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Good news could be in store for all three of these drugmakers. 
Via The Motley Fool
News headline image
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
The Top 3 Biotech Stocks to Buy in March 2024 ↗
Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. 
Via InvestorPlace
News headline image
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market ↗
All three have exciting programs on the way. 
Via The Motley Fool
News headline image
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making ↗
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward. 
Via InvestorPlace
News headline image
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. 
Via InvestorPlace
News headline image
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential ↗
Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Why Editas Medicine Stock Soared as Much as 42% Higher This Week ↗
The clinical-stage genome editing company dropped a couple of important announcements for shareholders. 
Via The Motley Fool
News headline image
3 Magnificent Growth Stocks to Buy in March ↗
These three stocks have two important common denominators: the same industry and tremendous growth prospects. 
Via The Motley Fool
News headline image
Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List ↗
Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant. 
Via Benzinga
News headline image
These 4 Stocks Are the "Magnificent Seven" of Healthcare ↗
Their growth trajectories aren't as meteoric, but they're still notable. 
Via The Motley Fool
News headline image
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks? ↗
These stocks meet many of the criteria long-term investors look for. 
Via The Motley Fool
News headline image
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug ↗
Both companies are working on treatments for genetic disorders. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks Bound to Blast Off By 2029 ↗
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years. 
Via InvestorPlace
News headline image
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT 
Via MarketBeat
News headline image
Vertex Pharmaceuticals (VRTX) Should Remain Supported ↗
Vertex Pharmaceuticals Incorporated (VRTX​​​​​​​), is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF). 
Via Talk Markets
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Vertex shares have climbed almost 50% over the past year. 
Via The Motley Fool
News headline image
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices ↗
Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs. 
Via Benzinga
News headline image
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv 
Via MarketBeat
Topics Artificial Intelligence
News headline image
The Ultimate Growth Stock to Buy With $1,000 Right Now ↗
The positives are many and the negatives are few with this high-flying stock. 
Via The Motley Fool
News headline image
2 Stocks That Could Crush the Market in 2024 ↗
These companies aren't slowing down, and their addressable markets are widening. 
Via The Motley Fool
News headline image
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points ↗
Watch these five stocks, but the market is slightly extended. 
Via Investor's Business Daily
Topics Stocks
News headline image
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
News headline image
The Best Stocks to Invest $5,000 in Right Now ↗
These stocks could be huge winners for long-term investors. 
Via The Motley Fool
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.